3513: ATM inhibition with AZD1390 and conventional radiotherapy in non-small cell lung cancer: interim report from the CONCORDE phase Ib trial (NCT04550104)

Walls, G., Horne, A., Harrow, S. et al. (17 more authors) (2025) 3513: ATM inhibition with AZD1390 and conventional radiotherapy in non-small cell lung cancer: interim report from the CONCORDE phase Ib trial (NCT04550104). In: Radiotherapy and Oncology. ESTRO 2025, 02-06 May 2025, Vienna, Austria. , s1395-s1397.

Metadata

Item Type: Proceedings Paper
Authors/Creators:
  • Walls, G.
  • Horne, A.
  • Harrow, S.
  • Hatton, M. ORCID logo https://orcid.org/0000-0003-2778-7926
  • Shaw, P.
  • Rizos, K.
  • Rothwell, D.
  • Ojo, O.
  • Stavraka, C.
  • Glover, C.
  • Hassani, A.
  • Walker, F.
  • Kendall, J.
  • Norris, M.
  • Phillip, R.
  • Oughton, J.
  • Chalmers, A.
  • Brown, S.
  • Faivre-Finn, C.
  • Greystoke, A.
Copyright, Publisher and Additional Information:

© 2025 The Authors. Except as otherwise noted, this author-accepted version of a poster published in Radiotherapy and Oncology is made available via the University of Sheffield Research Publications and Copyright Policy under the terms of the Creative Commons Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/

Keywords: Platform trial; lung radiotherapy; radiosensitiser
Dates:
  • Published (online): 21 May 2025
  • Published: May 2025
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 11 Jul 2025 15:41
Last Modified: 11 Jul 2025 15:41
Status: Published
Refereed: Yes
Identification Number: 10.1016/S0167-8140(25)01767-0
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics